This work is licensed under the Creative Commons Attribution 4.0 International License.
Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659–76. PMID: 14100514StarzlTEMarchioroTLVonkaullaKNHermannGBrittainRSWaddellWRHomotransplantation of the liver in humans196311765976PMID: 14100514Search in Google Scholar
Song AT, Avelino-Silva VI, Pecora RA, Pugliese V, D’Albuquerque LA, Abdala E. Liver transplantation: fifty years of experience. World J Gastroenterol 2014; 20: 5363–74. doi: 10.3748/wjg.v20.i18.5363SongATAvelino-SilvaVIPecoraRAPuglieseVD’AlbuquerqueLAAbdalaELiver transplantation: fifty years of experience20142053637410.3748/wjg.v20.i18.5363Open DOISearch in Google Scholar
Polyak A, Kuo A, Sundaram V. Evolution of liver transplant organ allocation policy: current limitations and future directions. World J Hepatol 2021; 13: 830–9. doi: 10.4254/with.v13.i8.830PolyakAKuoASundaramVEvolution of liver transplant organ allocation policy: current limitations and future directions202113830910.4254/with.v13.i8.830Open DOISearch in Google Scholar
Deng M, Ng SWY, Cheung ST, Chong CCN. Clinical application of Albumin-Bilirubin (ALBI) scores: the current status. Surgeon 2020; 18: 178–86. doi: 10.1016/j.surge.2019.09.002DengMNgSWYCheungSTChongCCNClinical application of Albumin-Bilirubin (ALBI) scores: the current status2020181788610.1016/j.surge.2019.09.002Open DOISearch in Google Scholar
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 16–31. doi: 10.1093/ageing/afy169Cruz-JentoftAJBahatGBauerJBoirieYBruyèreOCederholmTSarcopenia: revised European consensus on definition and diagnosis201948163110.1093/ageing/afy169Open DOISearch in Google Scholar
Reginster JY, Beaudart C, Al-Daghri N, Avouac B, Bauer J, Bere N, et al. Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults. Aging Clin Exp Res 2021; 33: 3–17. doi: 10.1007/s40520-020-01663-4ReginsterJYBeaudartCAl-DaghriNAvouacBBauerJBereNUpdate on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults20213331710.1007/s40520-020-01663-4Open DOISearch in Google Scholar
Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, et al. Health, aging, and body. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 2009; 90: 1579–85. doi: 10.3945/ajcn.2009.28047DelmonicoMJHarrisTBVisserMParkSWConroyMBVelasquez-MieyerPHealth, aging, and body. Longitudinal study of muscle strength, quality, and adipose tissue infiltration20099015798510.3945/ajcn.2009.28047Open DOISearch in Google Scholar
Miljkovic I, Kuipers AL, Cvejkus R, Bunker CH, Patrick AL, Gordon CL, el al. Myosteatosis increases with aging and is associated with incident diabetes in African ancestry men. Obesity 2016; 24: 476–82. doi: 10.1002/oby.21328MiljkovicIKuipersALCvejkusRBunkerCHPatrickALGordonCLMyosteatosis increases with aging and is associated with incident diabetes in African ancestry men2016244768210.1002/oby.21328Open DOISearch in Google Scholar
Montano-Loza AJ, Angulo P, Meza-Junco J, Prado CM, Sawyer MB, Beaumont C, et al. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle 2015; 7: 126–35. doi: 10.1002/jcsm.12039Montano-LozaAJAnguloPMeza-JuncoJPradoCMSawyerMBBeaumontCSarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis201571263510.1002/jcsm.12039Open DOISearch in Google Scholar
Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 2000; 49: 467–72. doi: 10.1016/s0026-0495(00)80010-4GoodpasterBHTheriaultRWatkinsSCKelleyDEIntramuscular lipid content is increased in obesity and decreased by weight loss2000494677210.1016/s0026-0495(00)80010-4Open DOISearch in Google Scholar
Lee CM, Kang J. Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2020; 11: 1270–82. doi: 10.1002/jcsm.12575LeeCMKangJPrognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis20201112708210.1002/jcsm.12575Open DOISearch in Google Scholar
Srpcic M, Jordan T, Popuri K, Sok M. Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer. Radiol Oncol 2020; 54: 237–46. doi: 10.2478/raon-2020-0016SrpcicMJordanTPopuriKSokMSarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer2020542374610.2478/raon-2020-0016Open DOISearch in Google Scholar
Espinosa-Flores AJ, Guzman-Ortiz E, Melendez-Mier G, Ternovoy SK, Bueno-Hernandez N, Roldan-Valadez E. A scoping review of the methods used in patients with liver cirrhosis to assess body composition and their nutritional findings. [Ahead of print]. Eur J Clin Nutr 2023. doi:10.1038/s41430-023-01287-7Espinosa-FloresAJGuzman-OrtizEMelendez-MierGTernovoySKBueno-HernandezNRoldan-ValadezEA scoping review of the methods used in patients with liver cirrhosis to assess body composition and their nutritional findings. [Ahead of print]202310.1038/s41430-023-01287-7Open DOISearch in Google Scholar
Lee CM, Kang BK, Kim M. Radiologic definition of sarcopenia in chronic liver disease. Life (Basel) 2021; 11: 86. doi: 10.3390/life11020086LeeCMKangBKKimMRadiologic definition of sarcopenia in chronic liver disease2021118610.3390/life11020086Open DOISearch in Google Scholar
Kjønigsen LJ, Harneshaug M, Fløtten AM, Karterud LK, Petterson K, Skjolde G, et al. Reproducibility of semiautomated body composition segmentation of abdominal computed tomography: a multiobserver study. Eur Radiol Exp 2019; 3: 42. doi: 10.1186/s41747-019-0122-5KjønigsenLJHarneshaugMFløttenAMKarterudLKPettersonKSkjoldeGReproducibility of semiautomated body composition segmentation of abdominal computed tomography: a multiobserver study201934210.1186/s41747-019-0122-5Open DOISearch in Google Scholar
Jensen GL, Cederholm T, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community. JPEN J Parenter Enteral Nutr 2019; 43: 32–40. doi: 10.1002/jpen.1440JensenGLCederholmTCorreiaMITDGonzalezMCFukushimaRHigashiguchiTGLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community201943324010.1002/jpen.1440Open DOISearch in Google Scholar
Song HN, Wang WB, Luo X, Huang DD, Ruan XJ, Xing CG, et al. Effect of GLIM-defined malnutrition on postoperative clinical outcomes in patients with colorectal cancer. Jpn J Clin Oncol 2022; 52: 466–74. doi: 10.1093/jjco/hyab215.SongHNWangWBLuoXHuangDDRuanXJXingCGEffect of GLIM-defined malnutrition on postoperative clinical outcomes in patients with colorectal cancer2022524667410.1093/jjco/hyab215Open DOISearch in Google Scholar
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–13. doi: 10.1097/01.sla.0000133083.54934.aeDindoDDemartinesNClavienPAClassification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey20042402051310.1097/01.sla.0000133083.54934.aeOpen DOISearch in Google Scholar
Venturi C, Sempoux C, Bueno J, Ferreres Pinas JC, Bourdeaux C, Abarca-Quinones J, et al. Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children. Am J Transplant 2012; 12: 2986–96. doi: 10.1111/j.1600-6143.2012.04210.xVenturiCSempouxCBuenoJFerreres PinasJCBourdeauxCAbarca-QuinonesJNovel histologic scoring system for long-term allograft fibrosis after liver transplantation in children20121229869610.1111/j.1600-6143.2012.04210.xOpen DOISearch in Google Scholar
Popuri K, Cobzas D, Esfandiari N, Baracos V, Jagersand M. Body composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle. IEEE Trans Med Imaging 2016; 35: 512–20. doi: 10.1109/TMI.2015.2479252PopuriKCobzasDEsfandiariNBaracosVJagersandMBody composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle2016355122010.1109/TMI.2015.2479252Open DOISearch in Google Scholar
van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, IJzermans JN. Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J Transplant 2016; 16: 2277–92. doi: 10.1111/ajt.13732van VugtJLLevolgerSde BruinRWvan RosmalenJMetselaarHJIJzermansJNSystematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation20161622779210.1111/ajt.13732Open DOISearch in Google Scholar
Ebadi M, Tsien C, Bhanji RA, Dunichand-Hoedl AR, Rider E, Motamedrad M, et al. Myosteatosis in cirrhosis: a review of diagnosis, pathophysiological mechanisms and potential interventions. Cells 2022; 11: 1216. doi: 10.3390/cells11071216EbadiMTsienCBhanjiRADunichand-HoedlARRiderEMotamedradMMyosteatosis in cirrhosis: a review of diagnosis, pathophysiological mechanisms and potential interventions202211121610.3390/cells11071216Open DOISearch in Google Scholar
Eslamparast T, Montano-Loza AJ, Raman M, Tandon P. Sarcopenic obesity in cirrhosis − the confluence of 2 prognostic titans. Liver Int 2018; 38: 1706–17. doi: 10.1111/liv.13876EslamparastTMontano-LozaAJRamanMTandonPSarcopenic obesity in cirrhosis – the confluence of 2 prognostic titans20183817061710.1111/liv.13876Open DOISearch in Google Scholar
Czigany Z, Kramp W, Bednarsch J, van der Kroft G, Boecker J, Strnad P, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation. Am J Transplant 2020; 20: 493–503. doi: 10.1111/ajt.15577CziganyZKrampWBednarschJvan der KroftGBoeckerJStrnadPMyosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation20202049350310.1111/ajt.15577Open DOISearch in Google Scholar
Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol 2016; 65: 1232–44. doi: 10.1016/j.jhep.2016.07.040DasarathySMerliMSarcopenia from mechanism to diagnosis and treatment in liver disease20166512324410.1016/j.jhep.2016.07.040Open DOISearch in Google Scholar
Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol 2019; 54: 845–59. doi:10.1007/s00535-019-01605-6EbadiMBhanjiRAMazurakVCMontano-LozaAJSarcopenia in cirrhosis: from pathogenesis to interventions2019548455910.1007/s00535-019-01605-6Open DOISearch in Google Scholar
Montano-Loza AJ. Skeletal muscle abnormalities and outcomes after liver transplantation. Liver Transpl 2014; 20: 1293–95. doi: 10.1002/lt.23995Montano-LozaAJSkeletal muscle abnormalities and outcomes after liver transplantation20142012939510.1002/lt.23995Open DOISearch in Google Scholar
Kim HY, Jang JW. Sarcopenia in the prognosis of cirrhosis: going beyond the MELD score. World J Gastroenterol 2015; 21: 7637–47. doi: 10.3748/wjg.v21.i25.7637KimHYJangJWSarcopenia in the prognosis of cirrhosis: going beyond the MELD score20152176374710.3748/wjg.v21.i25.7637Open DOISearch in Google Scholar
Levolger S, van Vugt JLA, de Bruin RWF, IJzermans JNM. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg 2015, 102: 1448–58. doi: 10.1002/bjs.9893LevolgerSvan VugtJLAde BruinRWFIJzermansJNMSystematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies201510214485810.1002/bjs.9893Open DOISearch in Google Scholar
Cao Q, Xiong Y, Zhong Z, Ye Q. Computed tomography-assessed sarcopenia indexes predict major complications following surgery for hepatopancreatobiliary malignancy: a meta-analysis. Ann Nutr Metab 2019; 74: 24–34. doi: 10.1159/000494887CaoQXiongYZhongZYeQComputed tomography-assessed sarcopenia indexes predict major complications following surgery for hepatopancreatobiliary malignancy: a meta-analysis201974243410.1159/000494887Open DOISearch in Google Scholar
Kaibori M, Ishizaki M, Iida H, Matsui K, Sakaguchi T, Inoue K, et al. Effect of intramuscular adipose tissue content on prognosis in patients undergoing hepatocellular carcinoma resection. J Gastrointest Surg 2015; 19: 1315–23. doi: 10.1007/s11605-015-2838-8KaiboriMIshizakiMIidaHMatsuiKSakaguchiTInoueKEffect of intramuscular adipose tissue content on prognosis in patients undergoing hepatocellular carcinoma resection20151913152310.1007/s11605-015-2838-8Open DOISearch in Google Scholar
Ooi PH, Hager A, Mazurak VC, Dajani K, Bhargava R, Gilmour SM, et al. Sarcopenia in chronic liver disease: impact on outcomes. Liver Transpl 2019; 25: 1422–38. doi: 10.1002/lt.25591OoiPHHagerAMazurakVCDajaniKBhargavaRGilmourSMSarcopenia in chronic liver disease: impact on outcomes20192514223810.1002/lt.25591Open DOISearch in Google Scholar
Weerink LBM, van der Hoorn A, van Leeuwen BL, de Bock GH. Low skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2020; 11: 636–49. doi: 10.1002/jcsm.12529WeerinkLBMvan der HoornAvan LeeuwenBLde BockGHLow skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta-analysis2020116364910.1002/jcsm.12529Open DOISearch in Google Scholar
Hsu CS, Kao JH. Sarcopenia and chronic liver diseases. Expert Rev Gastroenterol Hepatol 2018; 12: 1229–44. doi: 10.1080/17474124.2018.1534586HsuCSKaoJHSarcopenia and chronic liver diseases20181212294410.1080/17474124.2018.1534586Open DOISearch in Google Scholar
Pinto Dos Santos D, Kloeckner R, Koch S, Hoppe-Lotichius M, Zöller D, Toenges G, et al. Sarcopenia as prognostic factor for survival after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2020; 32: 626–34. doi: 10.1097/MEG.0000000000001552Pinto Dos SantosDKloecknerRKochSHoppe-LotichiusMZöllerDToengesGSarcopenia as prognostic factor for survival after orthotopic liver transplantation2020326263410.1097/MEG.0000000000001552Open DOISearch in Google Scholar
Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166–73, 173.e1. doi: 10.1016/j.cgh.2011.08.028Montano-LozaAJMeza-JuncoJPradoCMLieffersJRBaracosVEBainVGMuscle wasting is associated with mortality in patients with cirrhosis20121016673173.e110.1016/j.cgh.2011.08.028Open DOISearch in Google Scholar
Lucidi C, Lattanzi B, Di Gregorio V, Incicco S, D’Ambrosio D, Venditti M, et al. A low muscle mass increases mortality in compensated cirrhotic patients with sepsis. Liver Int 2018; 38: 851–7. doi: 10.1111/liv.13691LucidiCLattanziBDi GregorioVInciccoSD’AmbrosioDVendittiMA low muscle mass increases mortality in compensated cirrhotic patients with sepsis201838851710.1111/liv.13691Open DOISearch in Google Scholar
Chang KV, Chen JD, Wu WT, Huang KC, Lin HY, Han DS. Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis. J Formos Med Assoc 2019; 118: 833–42. doi: 10.1016/j.jfma.2018.09.011ChangKVChenJDWuWTHuangKCLinHYHanDSIs sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis20191188334210.1016/j.jfma.2018.09.011Open DOISearch in Google Scholar
Lattanzi B, D’Ambrosio D, Merli M. Hepatic encephalopathy and sarcopenia: two faces of the same metabolic alteration. J Clin Exp Hepatol 2019; 9: 125–13. doi: 10.1016/j.jceh.2018.04.007LattanziBD’AmbrosioDMerliMHepatic encephalopathy and sarcopenia: two faces of the same metabolic alteration201991251310.1016/j.jceh.2018.04.007Open DOISearch in Google Scholar
Dhaliwal A, Larson D, Hiat M, Muinov LM, Harrison WL, Sayles H, et al. Impact of sarcopenia on mortality in patients undergoing liver re-transplantation. World J Hepatol 2020; 12: 807–15. doi: 10.4254/wjh.v12.i10.807DhaliwalALarsonDHiatMMuinovLMHarrisonWLSaylesHImpact of sarcopenia on mortality in patients undergoing liver re-transplantation2020128071510.4254/wjh.v12.i10.807Open DOISearch in Google Scholar
Lee CM, Kang BK, Kim M. Radiologic definition of sarcopenia in chronic liver disease. Life 2021; 11: 86. doi: 10.3390/life11020086LeeCMKangBKKimMRadiologic definition of sarcopenia in chronic liver disease2021118610.3390/life11020086Open DOISearch in Google Scholar
Meeks AC, Madill J. Sarcopenia in liver transplantation: a review. Clin Nutr ESPEN 2017; 22: 76–80. doi: 10.1016/j.clnesp.2017.08.005MeeksACMadillJSarcopenia in liver transplantation: a review201722768010.1016/j.clnesp.2017.08.005Open DOISearch in Google Scholar
van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, IJzermans JN. Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J Transplant 2016; 16: 2277–92. doi: 10.1111/ajt.13732van VugtJLLevolgerSde BruinRWvan RosmalenJMetselaarHJIJzermansJNSystematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation20161622779210.1111/ajt.13732Open DOISearch in Google Scholar
Yao J, Zhou X, Yuan L, Niu LY, Zhang A, Shi H, et al. Prognostic value of the third lumbar skeletal muscle mass index in patients with liver cirrhosis and ascites. Clin Nutr 2020; 39: 1908–13. doi: 10.1016/j.clnu.2019.08.006YaoJZhouXYuanLNiuLYZhangAShiHPrognostic value of the third lumbar skeletal muscle mass index in patients with liver cirrhosis and ascites20203919081310.1016/j.clnu.2019.08.006Open DOISearch in Google Scholar
Kappus MR, Wegermann K, Bozdogan E, Patel YA, Janas G, Shropshire E, et al. Use of skeletal muscle index as a predictor of wait-list mortality in patients with end-stage liver disease. Liver Transpl 2020; 26: 1090–9. doi: 10.1002/lt.25802KappusMRWegermannKBozdoganEPatelYAJanasGShropshireEUse of skeletal muscle index as a predictor of wait-list mortality in patients with end-stage liver disease2020261090910.1002/lt.25802Open DOISearch in Google Scholar
Aby ES, Lee E, Saggi SS, Viramontes MR, Grotts JF, Agopian VG, et al. Pretransplant sarcopenia in patients with NASH cirrhosis does not impact rehospitalization or mortality. J Clin Gastroenterol 2019; 53: 680–5. doi: 10.1097/MCG.0000000000001109AbyESLeeESaggiSSViramontesMRGrottsJFAgopianVGPretransplant sarcopenia in patients with NASH cirrhosis does not impact rehospitalization or mortality201953680510.1097/MCG.0000000000001109Open DOISearch in Google Scholar
Czigany Z, Kramp W, Lurje I, Miller H, Bednarsch J, Lang SA, et al. The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation. J Cachexia Sarcopenia Muscle 2021; 12: 358–67. doi: 10.1002/jcsm.12669CziganyZKrampWLurjeIMillerHBednarschJLangSAThe role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation2021123586710.1002/jcsm.12669Open DOISearch in Google Scholar
Nelke C, Dziewas R, Minnerup J, Meuth SG, Ruck T. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine 2019; 49: 381–8. doi: 10.1016/j.ebiom.2019.10.034NelkeCDziewasRMinnerupJMeuthSGRuckTSkeletal muscle as potential central link between sarcopenia and immune senescence201949381810.1016/j.ebiom.2019.10.034Open DOISearch in Google Scholar
Wakabayashi T, Shinoda M, Obara H, Kitago M, Yagi H, Abe Y, et al. Decreased incidence of acute cellular rejection in low-muscle-mass recipients after living-donor liver transplantation. Transplant Proc 2018; 50: 3626–34. doi: 10.1016/j.transproceed.2018.06.028WakabayashiTShinodaMObaraHKitagoMYagiHAbeYDecreased incidence of acute cellular rejection in low-muscle-mass recipients after living-donor liver transplantation20185036263410.1016/j.transproceed.2018.06.028Open DOISearch in Google Scholar
Bellido D, García-García C, Talluri A, Lukaski HC, García-Almeida JM. Future lines of research on phase angle: strengths and limitations. Rev Endocr Metab Disord 2023; 24: 563–83. doi: 10.1007/s11154-023-09803-7BellidoDGarcía-GarcíaCTalluriALukaskiHCGarcía-AlmeidaJMFuture lines of research on phase angle: strengths and limitations2023245638310.1007/s11154-023-09803-7Open DOISearch in Google Scholar
Lee CM, Kang BK, Kim M. Radiologic definition of sarcopenia in chronic liver disease. Life 2021; 11: 86. doi: 10.3390/life11020086LeeCMKangBKKimMRadiologic definition of sarcopenia in chronic liver disease2021118610.3390/life11020086Open DOISearch in Google Scholar
Kallwitz ER. Sarcopenia and liver transplant: the relevance of too little muscle mass. World J Gastroenterol 2015; 21: 10982–93. doi: 10.3748/wjg.v21.i39.10982KallwitzERSarcopenia and liver transplant: the relevance of too little muscle mass201521109829310.3748/wjg.v21.i39.10982Open DOISearch in Google Scholar
Lindqvist C, Brismar TB, Majeed A, Wahlin S. Assessment of muscle mass depletion in chronic liver disease: dual-energy x-ray absorptiometry compared with computed tomography. Nutrition 2019; 61: 93–8. doi: 10.1016/j.nut.2018.10.031LindqvistCBrismarTBMajeedAWahlinSAssessment of muscle mass depletion in chronic liver disease: dual-energy x-ray absorptiometry compared with computed tomography20196193810.1016/j.nut.2018.10.031Open DOISearch in Google Scholar
Shenvi SD, Taber DJ, Hardie AD, Botstein JO, McGillicuddy JW. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB (Oxford) 2020; 22: 102–8. doi: 10.1016/j.hpb.2019.06.006ShenviSDTaberDJHardieADBotsteinJOMcGillicuddyJWAssessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients202022102810.1016/j.hpb.2019.06.006Open DOISearch in Google Scholar
Ahn H, Kim DW, Ko Y, Ha J, Shin YB, Lee J, et al. Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: a new paradigm beyond sarcopenia. Ageing Res Rev 2021; 70: 101398. doi: 10.1016/j.arr.2021.101398AhnHKimDWKoYHaJShinYBLeeJUpdated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: a new paradigm beyond sarcopenia20217010139810.1016/j.arr.2021.101398Open DOISearch in Google Scholar
Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31:1539–47. doi: 10.1200/JCO.2012.45.2722MartinLBirdsellLMacdonaldNReimanTClandininMTMcCargarLJCancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index20133115394710.1200/JCO.2012.45.2722Open DOISearch in Google Scholar
Loosen SH, Schulze-Hagen M, Püngel T, Bündgens L, Wirtz T, Kather JN, et al. Skeletal muscle composition predicts outcome in critically Ill patients. Crit Care Explor 2020; 2: e0171. doi: 10.1097/CCE.0000000000000171LoosenSHSchulze-HagenMPüngelTBündgensLWirtzTKatherJNSkeletal muscle composition predicts outcome in critically Ill patients20202e017110.1097/CCE.0000000000000171Open DOISearch in Google Scholar
Kim HY, Jang JW. Sarcopenia in the prognosis of cirrhosis: going beyond the MELD score. World J Gastroenterol 2015; 21: 7637–47. doi: 10.3748/wjg.v21.i25.7637KimHYJangJWSarcopenia in the prognosis of cirrhosis: going beyond the MELD score20152176374710.3748/wjg.v21.i25.7637Open DOISearch in Google Scholar
Francoz C, Prié D, Abdelrazek W, Moreau R, Mandot A, Belghiti J, et al. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl 2010; 16: 1169–77. doi: 10.1002/lt.22128FrancozCPriéDAbdelrazekWMoreauRMandotABelghitiJInaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score20101611697710.1002/lt.22128Open DOISearch in Google Scholar
Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, et al. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation. Clin Nutr 2020; 39: 1885–92. doi: 10.1016/j.clnu.2019.08.012HamaguchiYKaidoTOkumuraSKobayashiAShiraiHYaoSIncluding body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation20203918859210.1016/j.clnu.2019.08.012Open DOISearch in Google Scholar
Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JX, et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol 2015; 6: e102. doi: 10.1038/ctg.2015.31Montano-LozaAJDuarte-RojoAMeza-JuncoJBaracosVESawyerMBPangJXInclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis20156e10210.1038/ctg.2015.31Open DOISearch in Google Scholar
van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, et al. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort. J Hepatol 2018; 68: 707–14. doi: 10.1016/j.jhep.2017.11.030van VugtJLAAlferinkLJMBuettnerSGasperszMPBotDDarwish MuradSA model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort2018687071410.1016/j.jhep.2017.11.030Open DOISearch in Google Scholar
Chedid MF, Picon RV, Chedid AD. ALBI and PALBI: novel scores for outcome prediction of cirrhotic outpatients awaiting liver transplantation. Ann Hepatol 2018; 17: 906–7. doi: 10.5604/01.3001.0012.7190ChedidMFPiconRVChedidADALBI and PALBI: novel scores for outcome prediction of cirrhotic outpatients awaiting liver transplantation201817906710.5604/01.3001.0012.7190Open DOISearch in Google Scholar
Bernardi N, Chedid MF, Grezzana-Filho TJM, Chedid AD, Pinto MA, Leipnitz I, et al. Pre-transplant ALBI grade 3 is associated with increased mortality after liver transplantation. Dig Dis Sci 2019; 64: 1695–704. doi: 10.1007/s10620-019-5456-6BernardiNChedidMFGrezzana-FilhoTJMChedidADPintoMALeipnitzIPre-transplant ALBI grade 3 is associated with increased mortality after liver transplantation201964169570410.1007/s10620-019-5456-6Open DOISearch in Google Scholar
Miarka M, Gibiński K, Janik MK, Główczyńska R, Zając K, Pacho R, et al. Sarcopenia-the impact on physical capacity of liver transplant patients. Life 2021; 11: 740. doi: 10.3390/life11080740.MiarkaMGibińskiKJanikMKGłówczyńskaRZającKPachoRSarcopenia-the impact on physical capacity of liver transplant patients20211174010.3390/life11080740Open DOISearch in Google Scholar
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol 2019; 70: 172–93. doi: 10.1016/j.jhep.2018.06.024European Association for the Study of the LiverEASL Clinical Practice Guidelines on nutrition in chronic liver disease2019701729310.1016/j.jhep.2018.06.024Open DOISearch in Google Scholar
Maharshi S, Sharma BC, Sachdeva S, Srivastava S, Sharma P. Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial. Clin Gastroenterol Hepatol 2016; 14: 454–60. e453. doi: 10.1016/j.cgh.2015.09.028MaharshiSSharmaBCSachdevaSSrivastavaSSharmaPEfficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial20161445460e45310.1016/j.cgh.2015.09.028Open DOISearch in Google Scholar
Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol 2019; 54: 845–59. doi: 10.1007/s00535-019-01605-6EbadiMBhanjiRAMazurakVCMontano-LozaAJSarcopenia in cirrhosis: from pathogenesis to interventions2019548455910.1007/s00535-019-01605-6Open DOISearch in Google Scholar
Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol 2016; 65: 1232–44. doi: 10.1016/j.jhep.2016.07.040DasarathySMerliMSarcopenia from mechanism to diagnosis and treatment in liver disease20166512324410.1016/j.jhep.2016.07.040Open DOISearch in Google Scholar
Berzigotti A, Albillos A, Villanueva C, Genesca J, Ardevol A, Augustin S, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology 2017; 65: 1293–305. doi: 10.1002/hep.28992BerzigottiAAlbillosAVillanuevaCGenescaJArdevolAAugustinSEffects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study201765129330510.1002/hep.28992Open DOISearch in Google Scholar
Stokes CS, Volmer DA, Grunhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int 2013; 33: 338–52. doi: 10.1111/liv.12106StokesCSVolmerDAGrunhageFLammertFVitamin D in chronic liver disease2013333385210.1111/liv.12106Open DOISearch in Google Scholar
Miarka M, Gibiński K, Janik MK, Główczyńska R, Zając K, Pacho R, et al. Sarcopenia-the Impact on physical capacity of liver transplant patients. Life 2021; 11: 740. doi: 10.3390/life11080740MiarkaMGibińskiKJanikMKGłówczyńskaRZającKPachoRSarcopenia-the Impact on physical capacity of liver transplant patients20211174010.3390/life11080740Open DOISearch in Google Scholar
Lei Q, Wang X, Zheng H, Bi J, Tan S, Li N. Peri-operative immunonutrition in patients undergoing liver transplantation: a meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr 2015; 24: 583–90. doi: 10.6133/apjcn.2015.24.4.20.LeiQWangXZhengHBiJTanSLiNPeri-operative immunonutrition in patients undergoing liver transplantation: a meta-analysis of randomized controlled trials2015245839010.6133/apjcn.2015.24.4.20Open DOISearch in Google Scholar